Drug Labeling Studies In The International Literature: A Biometric Analysis
DOI:
https://doi.org/10.5281/zenodo.13825345Keywords:
Drug Labeling, Bibliometric Analysis, HealthcareAbstract
This study aims to examine the literature on drug labeling scanned in the Scopus database from a bibliometric perspective. A total of 2540 articles were considered for analysis and the data were evaluated with VOSviewer 1.6.19 software. When the findings are examined, the first study on drug labeling was conducted in 1955 (1). The highest number of articles was published in 2021 (191 articles). The majority of the articles were written in English (2464). 79.6% of the studies (2022) were classified as research articles. 46.7% of the articles (1915) were published in the field of medicine. Wolf MS is the most productive author with 20 articles and the most cited author with 323 citations. The British Journal of Clinical Pharmacology has received a total of 2188 citations with 55 articles. The United States is the most productive country with 1226 articles and has the highest number of links with 612. The term "drug labeling" is the most frequently used keyword (72). Studies on drug labeling in Turkey are quite limited. This study will provide researchers with a broad perspective on the subject and will provide a comprehensive panoramic assessment.
References
Aspden, P. Wolcott, J. Bootman, L. Cronenwett, LR. (2007). Preventing Medication Errors. National Academy Press. Washington DC.
Bates, DW. Cohen, M. Leape, LL. Overhage, JM. Shabot, MM. ve Sheridan, T. (2001). Reducing the Frequency of Errors in Medicine Using Information Technology. J Am Med Inform Assoc. 8(4):299-308.
Davis, TC. Federman, AD. Bass, PF. Jackson, RH. Middlebrooks, M. Parker, RM. ve Wolf, MS. (2009). Improving Patient Understanding of Prescription Drug Label Instructions. Journal of General Internal Medicine, 24, 57-62.
Duke, J. Friedlin, J. ve Ryan, P. (2011). A Quantitative Analysis of Adverse Events and “Overwarning” in Drug Labeling. Archives of Internal Medicine, 171(10), 941-954.
Eguale, T. Buckeridge, DL. Verma, A. Winslade, NE. Benedetti, A. Hanley, JA. ve Tamblyn, R. (2016). Association of Off-Label Drug Use and Adverse Drug Events in an Adult Population. JAMA Intern Med.; 176(1):55–63. doi:10.1001/jamainternmed.2015.6058.
Hernandez, LM. (Ed.). (2008). Standardizing Medication Labels: Confusing Patients Less: Workshop Summary. National Academies Press.
Houts, PS. Witmer, JT. Egeth, HE. Loscalzo, MJ. ve Zabora, JR. (2001). Using Pictographs to Enhance Recall of Spoken Medical Instructions II. Patient Education And Counseling, 43(3), 231-242.
Jang, HY. Song, J. Kim, JH. Lee, H. Kim, IW. Moon, B. ve Oh, JM. (2022). Machine Learning-Based Quantitative Prediction of Drug Exposure in Drug-Drug İnteractions Using Drug Label Information. NPJ Digital Medicine, 5(1), 88.
Jung, K. LePendu, P. Chen, WS. Iyer, SV. Readhead, B. Dudley, JT. ve Shah, NH. (2014). Automated Detection of Off-Label Drug Use. Plos One, 9(2), e89324.
Kimberlin, CL. Winterstein, AG. (2008). Expert and Consumer Evaluation of Consumer Medication Information-2008. Final report to the U.S. Department of Health and Human Servics and the Food and Drug Administration. Washington, DC: Food and Drug Administration. https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/RiskCommunicationAdvisoryCommittee/UCM117149.pdf
Mohan, A. Riley, MB. Boyington, D. Johnston, P. Trochez, K. Jennings, C. Mashburn, J. ve Kripalani, S. (2013). Development of a Patient-Centered Bilingual Prescription Drug Label. Journal of Health Communication, 18(sup1), 49–61. https://doi.org/10.1080/10810730.2013.825664
Murray, MD. Young, JM. Morrow, DG. Weiner, M. Tu, W., Hoke, S. C., ... ve Weinberger, M. (2004). Methodology of an Ongoing, Randomized, Controlled Trial to Improve Drug Use For Elderly Patients With Chronic Heart Failure. The American Journal of Geriatric Pharmacotherapy, 2(1), 53-65.
Pandolfini, C. ve Bonati, M. (2005). A Literature Review on Off-Label Drug Use in Children. European Journal Of Pediatrics. 164 , 552–558. https://doi.org/10.1007/s00431-005-1698-8
Sharif, I., Tse J. (2010). Accuracy of Computer-Generated, Spanish-Language Medicine Labels. Pediatrics. 125:960–965. doi: 10.1542/peds.2009-2530.
Shrank, WH. Agnew-Blais, J. Choudhry, NK. Wolf, MS. Kesselheim, AS. Avorn, J. Shekelle, P. (2007). The Variability and Quality of Medication Container Labels. Archives of Internal Medicine. 167:1760–1765.
Stafford, RS. (2008). Regulating Off-Label Drug Use—Rethinking the Role of the FDA. New England Journal of Medicine, 358(14), 1427-1429.
Türkiye İlaç ve Tıbbi Cihaz Kurumu (2017). Beşeri Tıbbi Ürünler Ruhsatlandırma Yönetmeliği.
Weiss, L. Gany, F. Rosenfeld, P. Carrasquillo, O. Sharif, I. Behar, E. Mangione, R. (2007). Access to Multilingual Medication Instructions at New York City Pharmacies. Journal of Urban Health. 84:742–754.
Wolf, MS. Davis, TC. Shrank, W. Rapp, DN. Bass, PF. Connor, UM. Parker, RM. (20027). To Err is Human: Patient Misinterpretations of Prescription Drug Label Instructions. Patient Education & Counseling. 2007;67:293–300.
Woodcock, J. Behrman, RE. ve Dal Pan GJ. (2011). Role of Postmarketing Surveillance in Contemporary Medicine. Annu Rev Med 2011; 62: 1–10.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 EJONS INTERNATIONAL JOURNAL
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
